JUN and cancer: In terms of restraining cSCC, all-trans-retinoic acid (ATRA) represses the overexpressed in some aggressive cancers’ activator protein-1 and diminishes activation of STAT3 in keratinocytes, whereas STAT3 encourages keratinocyte proliferation, which potentially leads to its later malignancy.